Hyris and Ulisse Biomed completed their integration to form a new biotech group.

Hyris and Ulisse Biomed have completed their integration, creating a new international biotech group. The partnership combines Hyris' disruptive genetic testing platform and Ulisse Biomed's innovative testing platforms to become a new benchmark of innovation in the global biotech market. The merger was officially ratified on December 21st after a reverse take-over transaction and a shareholders' meeting.

January 15, 2024
5 Articles